Latest Sales Growth News

Page 6 of 78
Comvita has moved from NZ$62.4 million of net debt to NZ$0.5 million of net cash in a year, while FY27 first-quarter sales rose 4.6%. The sharper test now is whether its operating reset can convert a stronger balance sheet into durable shareholder returns, with no FY27 dividend expected and board control still contested.
Victor Sage
Victor Sage
28 Oct 2026
Vicinity Centres has reaffirmed its FY27 earnings targets after a resilient first quarter, with occupancy steady at 99.6%, leasing spreads widening to 5.1% and portfolio sales rising 3.0%. The AGM also marked the retirement of chairman Trevor Gerber and director Tim Hammon.
Eva Park
Eva Park
28 Oct 2026
Vicinity Centres has reaffirmed its FY27 earnings guidance after a resilient first quarter, with occupancy steady at 99.6%, leasing spreads widening to 5.1% and total portfolio sales rising 3.0%. The AGM also marked Trevor Gerber’s retirement as chairman and the formal leadership transition to Patrick Allaway.
Eva Park
Eva Park
28 Oct 2026
PT ANTAM (Persero) Tbk (ASX:ATM, IDX:ANTM) delivered stronger nine-month 2026 operating volumes across gold, ferronickel, bauxite and alumina, while advancing Indonesia’s battery and mineral-processing agenda. The unaudited report also details Rp5.05 trillion in dividends, but provides no nine-month revenue or profit figures.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Nova Eye Medical delivered 30% year-on-year sales growth in the September quarter, alongside positive operating cash flow and EBITDA. The company confirmed FY27 guidance, but is still seeking to replace a related-party funding facility carrying 15% interest.
Victor Sage
Victor Sage
27 Oct 2026
Universal Store has opened FY27 with 9.3% growth in direct-to-customer sales, led by a sharp lift from Perfect Stranger. The retailer is maintaining its plan for 16 to 20 new stores despite continued weakness in CTC’s wholesale channel.
Logan Eniac
Logan Eniac
27 Oct 2026
Pure Foods Tasmania has reported a deeper FY26 loss, negative cash and a material uncertainty over its ability to continue as a going concern. The company says existing facilities may be insufficient from February 2027, with further equity funding uncommitted and a second bank covenant breach possible.
Victor Sage
Victor Sage
27 Oct 2026
ReNerve has reported its strongest quarter yet, with sales climbing to $584,000 as the medical device company expands across Asia-Pacific. The growth came alongside a secured funding drawdown, leaving the company with $1.62 million in cash but continued negative operating cash flow.
Victor Sage
Victor Sage
26 Oct 2026
FINEOS lifted its quarterly client receipts 47% and ended September with €51.7 million in cash, while maintaining FY26 revenue guidance of €147 million to €152 million. The stronger cash position was helped by the delayed collection of approximately €8 million in invoices, but no new sales were finalised during the quarter.
Victor Sage
Victor Sage
26 Oct 2026
Supply Network is targeting around $50 million of additional revenue in FY2027 after delivering 15.5% sales growth and expanding its Multispares network across Australia and New Zealand. The next phase includes a planned $9 million Penrith branch and further capacity upgrades, although the company has not quantified the earnings return from that investment.
Victor Sage
Victor Sage
23 Oct 2026
Firebrick Pharma is escalating Nasodine’s US push from online sales into retail pharmacies while its September-quarter cash balance fell to A$875,000. The company reported a A$398,000 operating cash outflow and estimated 2.2 quarters of funding at the current rate.
Victor Sage
Victor Sage
23 Oct 2026
Lovisa delivered another year of strong reported growth, with revenue rising 17.6% to A$938.8 million as its store network passed 1,100 locations. But comparable store sales grew just 2.0%, leaving management’s expansion engine carrying more of the load while executive incentive hurdles went unmet.
Logan Eniac
Logan Eniac
23 Oct 2026

Browse the archive

Full archive